INTRODUCTION {#s1}
============

Brachytherapy delivers a high radiation dose to the tumor while producing limited damage to the adjacent normal tissues. Therefore, this treatment modality preserves the shape and functions of the tongue and allows radiotherapy to be reserved for secondary malignancies of the head and neck \[[@RRT060C1]--[@RRT060C4]\]. Low-dose-rate brachytherapy using ^192^Ir hairpins or ^137^Cs needles is widely used for the treatment of early tongue cancer because it allows excellent local control rates that are comparable to those of surgery \[[@RRT060C1], [@RRT060C5], [@RRT060C6]\].

^198^Au grains are alternative sources used in our institution, usually prescribed for patients who cannot tolerate surgery, ^192^Ir hairpins, or ^137^Cs needles because of advanced patient age or poor performance status due to the presence of complications such as dementia, diabetes, or apoplexy \[[@RRT060C7], [@RRT060C8]\]. ^198^Au grains are small and can be easily applied under local anesthesia without causing severe pain or discomfort during the insertion and treatment \[[@RRT060C9]\]. They have a short half-life of 2.7 days, shortening the hospital stay and making subsequent complications less severe \[[@RRT060C9]\]. They are permanent implant sources, eliminating any re-traumatization of the tongue during grain extraction.

With the aging of Japan\'s population, the incidence rates of tongue cancer are also rising \[[@RRT060C10]\]. The demand for treatment with ^198^Au grains in elderly patients is also increasing in our institution. Knowing the clinical outcomes and prognostic factors of this treatment are thus important. However, to the best of our knowledge, this topic has not been previously reported. In this study, we retrospectively examined the clinical outcomes of a group of patients treated with ^198^Au grains (Au-group) and compared them with the outcomes of a group of patients treated with ^192^Ir hairpins (Ir-group).

MATERIALS AND METHODS {#s2}
=====================

From March 1993 to February 2008, a total of 429 patients diagnosed with primary squamous cell carcinoma of the oral tongue received interstitial brachytherapy at Tokyo Medical and Dental University Hospital. Of the 429 patients, 96 were treated with ^198^Au grains because of advanced age (≥75 years), or poor performance status ( ≥ 2 on the ECOG scale) due to complications such as dementia, diabetes, apoplexy, or chronic obstructive pulmonary disease (COPD). ^192^Ir hairpins were applied to 193 patients. The remaining patients were treated using ^137^Cs needles. We retrospectively examined the clinical outcomes of the Au-group and the Ir-group. We compared these two groups because we wanted to compare the result that could be achieved by applying ^198^Au grains to patients who cannot endure invasive therapy with the best possible result achieved by applying ^192^Ir hairpins. We excluded the Cs-group in this study because ^137^Cs needles are no longer available. This study was approved by the research ethics board committee of the university.

The patient characteristics are shown in Table [1](#RRT060TB1){ref-type="table"}. The mean age of the Au-group was 11 years higher than that of the Ir-group, which was a significant difference. All the patients with a performance status \>1 were treated with ^198^Au grains. The rate of patients with complications such as dementia, diabetes, apoplexy or COPD was higher in the Au-group than in the Ir-group, although the difference was not significant. All the complications in the Ir-group were controlled by medications, while all the complications in the Au-group were more severe than those in the Ir-group. All the lesions were histologically confirmed as squamous cell carcinoma and were staged as Stage I or II according to the UICC (International Union Against Cancer 2009) TNM classification \[[@RRT060C11]\]. The macroscopic appearances of the tumors were categorized as follows: (i) exophytic: tumors exhibiting external growth; (ii) superficial: flat tumors without palpable infiltration; or (iii) infiltrative: tumors penetrating deeply with or without ulceration. No significant differences in the T-factors or macroscopic appearances were observed between the two groups. Table 1.Patient characteristicsAu-group (*n* = 96)Ir-group (*n* = 193)*P*-valueAge (yrs)71 ± 1360 ± 14\<0.0001\*\*\*Sex (male/female)58/38134/590.15 Male (%)6069 Female (%)4031T-factor (T1/T2)43/5366/1270.09 T14534 T25566Complications (%)19110.10PS (Grade ≤ 1/Grade **≥** 2)(45/51)(193/0)\<0.0001\*\*\* Grade **≤** 1 (%)47100 Grade **≥** 2 (%)530Tumor type Superficial (%)47490.71 Exophytic (%)42400.80 Infiltrative (%)11111.0[^1]

^198^Au grains were inserted under local anesthesia. The nominal activity of each seed was 185 MBq, and single plane implants were routinely performed. After implantation, the patients were cared for in a shielding room for 3--7 days until the total radiation activity decreased to a level of 700 MBq. Five radiotherapists took turns to perform the insertion of the ^198^Au grains. The radiation exposure to the operators was \<40 µSv during each procedure. The most commonly prescribed dosage was 70 Gy over 7 days. The dosages were prescribed according to the dosage system reported by Paterson and Parker. Spacers were routinely prepared for brachytherapy performed after 1987 to prevent osteoradionecrosis. The grading system of postoperative complications defined by Shibuya *et al.* was used, as shown in Table [2](#RRT060TB2){ref-type="table"} \[[@RRT060C2]\]. All of the treatments were completed without any problems. Table 2.Definitions of soft tissue and mandibular complicationsGradeSoft tissue complicationMandibular complication**0**No ulcerNo change**I**Transient ulcer disappeared within 6 monthsTransient bone exposure disappeared spontaneously**II**Incurable ulcer lasted over 6 monthsBone necrosis healed by conservative treatment**III**Severe ulcer necessitating operationSevere bone necrosis necessitating operation

We examined the outcomes in terms of cause-specific survival, overall survival and local control/recurrence rates. The survival curves were calculated using the Kaplan-Meier method. The outcomes in the different groups were compared using a log-rank test. Univariate and multivariate analyses were performed using the Cox proportional hazards model. Four-fold point correlation coefficients (known as φ coefficients) were evaluated for the correlation analysis of categorical variables. The Welch *t*-test and the Fisher exact test were used to compare differences in parametric continuous variables and categorical variables, respectively. All the analyses used the conventional *P* \< 0.05 level of significance. The statistical analyses were performed using R, version 2.14.1.

RESULTS {#s3}
=======

Table [3](#RRT060TB3){ref-type="table"} compares the clinical outcomes of the two groups. The rate of postoperative complications, including tongue ulcers and osteoradionecrosis, were significantly lower in the Au-group than in the Ir-group. All the complications in the Au-group were Grade I, while about one-third of the complications in the Ir-group were Grade II. The 3-year and 5-year cause-specific survival rates were 73% and 71% in the Au-group, which were 15% and 16% lower than those in the Ir-group, respectively, which was statistically significant. Figure [1](#RRT060F1){ref-type="fig"} shows the cause-specific survival rates. The 3-year and 5-year local control rates were 71% and 68% in the Au-group, which were 17% and 16% lower than those in the Ir-group, which again was statistically significant. Figure [2](#RRT060F2){ref-type="fig"} shows the local control survival curves. The overall survival rates are also shown in Table [3](#RRT060TB3){ref-type="table"}. Table 3:Clinical outcomesAu-group (*n* = 96)Ir-group (*n* = 193)*P*-valuePrescribed dose (Gy)70 (8)70 (0)Follow-up period (yrs)3.9 ± 3.36.6 ± 4.2 Deceased patients (tongue cancer)2.0 ± 1.42.0 ± 2.2 Deceased patients (other cause)4.2 ± 5.25.0 ± 3.3 Surviving patients5.2 ± 3.07.7 ± 4.0Postoperative complications (%)8.3190.02\* Grade I (%)10069 Grade II (%)031Local recurrence (%)28160.03\*Cause-specific death (%)26150.02\*Lymph node metastases (%)24260.67Cause-specific survival rate0.003\*\* 3 yrs (%)7388 5 yrs (%)7187Overall survival rate0.001\*\* 3 yrs (%)5775 5 yrs (%)5172Local control rate0.002\*\* 3 yrs (%)7188 5 yrs (%)6886[^2] Fig. 1.Cause-specific survival curves for the Au-group and the Ir-group. Fig. 2.Local control survival curves for the Au-group and the Ir-group.

Table [4](#RRT060TB4){ref-type="table"} shows the results of the univariate analyses. In the Au-group, infiltrative-type lesions caused significantly more lymph-node metastases and tended to cause more local recurrences and deaths, although the differences were not significant. Superficial-type lesions tended to cause fewer deaths, but the difference was not significant. The prescribed dose was inversely and significantly related to the rate of local recurrence (unadjusted hazard ratio = 0.94, *P* = 0.03). Women had significantly more lymph-node metastases than men and tended to have a higher mortality rate, although the difference was not significant. In the Ir-group, superficial-type lesions caused significantly fewer lymph node metastases and deaths. Table 4.Univariate analysisAu-groupLocal recurrenceCause-specific deathLymph node metastasisUHR*P*-valueUHR*P*-valueUHR*P*-valueSex (male vs female)0.650.270.470.060.40.03\*Age1.010.471.020.351.010.68Tumor type (superficial)0.740.510.430.090.600.32Tumor type (infiltrative)2.100.142.150.113.270.02\*T-factor (T2 vs T1)1.980.111.150.721.340.49Prescribed dose0.940.03\*0.960.231.000.90**Ir-group**Sex (male vs female)1.070.861.390.450.950.85Age1.000.781.010.490.990.25Tumor type (superficial)0.570.170.230.005\*\*0.510.03\*Tumor type (infiltrative)1.480.431.720.220.970.93T-factor (T2 vs T1)1.900.141.650.251.360.32Prescribed dose0.990.900.970.650.980.65[^3]

Table [5](#RRT060TB5){ref-type="table"} shows the results of the multivariate analyses. In the Au-group, infiltrative-type lesions caused significantly more lymph node metastases. Superficial-type lesions tended to cause fewer deaths, but the difference was not significant. The prescribed dose was inversely related to the local recurrence rate, but not significantly. Women tended to have more lymph-node metastases and cause-specific deaths, but the differences were not significant. In the Ir-group, superficial-type lesions caused significantly fewer lymph node metastases and deaths. Table 5.Multivariate analysisAu-groupLocal recurrenceCause-specific deathLymph node metastasisAHR*P*-valueAHR*P*-valueAHR*P*-valueSex (male vs female)0.760.530.480.100.420.06Age1.010.681.010.551.000.92Tumor type (superficial)0.800.650.400.070.590.33Tumor type (infiltrative)1.620.372.140.143.580.02\*T-factor (T2 vs T1)1.320.560.530.180.690.46Prescribed dose0.950.100.970.291.010.82**Ir-group**Sex (male vs female)1.080.851.350.500.920.79Age1.000.761.010.420.990.29Tumor type (superficial)0.620.270.220.005\*\*0.490.03\*Tumor type (infiltrative)1.390.521.570.330.860.72T-factor (T2 vs T1)1.630.271.050.921.140.69Prescribed dose0.990.900.930.320.960.46[^4]

Correlation analyses showed that cause-specific deaths were related to local recurrences (φ = 0.49) and lymph-node metastases (φ = 0.49), but no correlation was seen between local recurrences and lymph-node metastases (φ = 0.097) in the Au-group. Similar results were also observed in the Ir-group (φ = 0.35, 0.35 and 0.10, respectively).

DISCUSSION {#s4}
==========

With the rapid aging of Japan\'s population, the incidence rates of tongue cancer with advanced age are also rising \[[@RRT060C10]\]. Most of these patients cannot undergo invasive surgery, brachytherapy using ^192^Ir hairpins or ^197^Cs needles, or chemoradiation \[[@RRT060C7]\]. One of the curative treatment modalities left is ^198^Au grains, because these grains can be applied under local anesthesia without producing pain or discomfort \[[@RRT060C7]\]. Our results showed that the differences in the cause-specific survival and local control rates between the Au-group and the Ir-group were less than 17%.

Thirty years ago, Slanina *et al.* reported their experience using ^189^Au grains in 32 patients with Stage I--III tongue cancer \[[@RRT060C12]\]. However, the mean age of their subjects was 61 years, which was 10 years younger than that of our study. Furthermore, they did not report any comorbid diseases in their patients. The 5-year cause-specific survival rate of their patients was comparable with that of our patients.

Infiltrative-type lesions tended to cause more lymph-node metastases, while superficial-type lesions tended to cause fewer. These results were consistent with those of a former study reported by Kirita *et al.* \[[@RRT060C13]\]. Our data also showed a tendency for the macroscopic appearances of the tumors to affect the cause-specific survival rates in the two groups. These results were consistent with previous studies \[[@RRT060C14]--[@RRT060C16]\]. To clarify this relation, we performed correlation analyses, as mentioned in the *Results*. The results showed that lymph-node metastasis was related to the cause-specific survival rates, in agreement with former studies \[[@RRT060C14], [@RRT060C17]--[@RRT060C19]\]. This finding suggests that the macroscopic appearances of the tumors affect the cause-specific deaths through lymph-node metastasis.

The univariate analysis showed that women had significantly more lymph-node metastases than men. The multivariate analysis also showed a tendency for women to have more lymph-node metastases, but the difference was not significant. This result was inconsistent with Yoshida *et al.*\'s study, which concluded that a male gender was a risk factor for lymph-node metastasis and cause-specific survival \[[@RRT060C20]\]. Further study of a larger population may be needed to clarify this inconsistency.

Our study did not show that age was a prognostic factor in either group. This result agrees with results of some previous studies \[[@RRT060C20]--[@RRT060C23]\]. However, this finding remains controversial because Yamazaki *et al.* showed that age was a potential prognostic factor \[[@RRT060C24]\].

CONCLUSION {#s5}
==========

In conclusion, our study showed the clinical outcomes of brachytherapy using ^198^Au grains for early-tongue-cancer patients of advanced age or poor performance status. With the aging of Japan\'s population, this minimal invasive therapy is becoming increasingly important and could be used as a curative treatment for these patients.

Clinical Trial Registration number of Tokyo Medical and Dental University: 1361.

[^1]: \*\*\**P* \< 0.001. Age is presented as the mean ± SD. PS = performance status

[^2]: The follow-up period is presented as the mean ± SD. The prescribed dosage is presented as the median (interquartile range) because it did not have a normal distribution. \**P* \< 0.05, \*\**P* \< 0.01.

[^3]: UHR = unadjusted hazard ratio. \**P* \< 0.05, \*\**P* \< 0.01.

[^4]: AHR = adjusted hazard ratio. \**P* \< 0.05, \*\**P* \< 0.01.
